Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

FILE - A sign for Eli Lilly & Co. appears outside their corporate headquarters in Indianapolis ... the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of 2024 while ...

Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro ... FILE - A sign for Eli Lilly & Co. appears outside their corporate headquarters in Indianapolis on April 26, 2017.

Eli Lilly’s profit doubled in ... better-than-expected 2025 forecast. Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter ...

The company has developed notable medications such as Prozac for depression, Humalog for diabetes, and Mounjaro for type 2 diabetes. Looking closer, Eli Lilly ... Inc. With headquarters in the ...